ロード中...
Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
Successful management of breast cancer in the metastatic setting is often confounded by resistance to chemotherapeutics, in particular anthracyclines and taxanes. The limited number of effective treatment options for patients with more aggressive biological subtypes, such as triple-negative metastat...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3356906/ https://ncbi.nlm.nih.gov/pubmed/22645612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/703858 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|